GINKGO BIOWORKS HOLDINGS, INC. (DNA) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 72.74M USD | Liabilities, Current |
| Cash and equivalents | 84.53M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 13.01M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $72.74M | $84.53M | (m) | $13.01M | (m) | (m) |
| 2026-03-31 | (m) | $79.59M | $143.86M | (m) | $19.82M | (m) | (m) |
| 2025-12-31 | $446.65M | $95.97M | $167.20M | $255.42M | $24.03M | (m) | 4.65× |
| 2025-09-30 | $516.91M | $115.28M | $111.06M | $384.42M | $21.43M | (m) | 4.48× |
| 2025-06-30 | $581.51M | $96.72M | $203.57M | $355.79M | $22.15M | (m) | 6.01× |
| 2025-03-31 | $351.55M | $115.67M | $312.42M | $12.84M | $26.29M | (m) | 3.04× |
| 2024-12-31 | (m) | $107.27M | $561.57M | (m) | $21.86M | (m) | (m) |
| 2024-09-30 | (m) | $114.43M | $616.21M | (m) | $23.41M | (m) | (m) |
| 2024-06-30 | (m) | $166.15M | $730.37M | (m) | $18.59M | (m) | (m) |
| 2024-03-31 | (m) | $169.04M | $840.44M | (m) | $24.19M | (m) | (m) |
| 2023-12-31 | (m) | $163.86M | $944.07M | (m) | $17.16M | $46.00K | (m) |
| 2023-09-30 | (m) | $168.46M | $1.05B | (m) | $61.90M | $70.00K | (m) |
| 2023-06-30 | (m) | $163.33M | $1.11B | (m) | $68.02M | $391.00K | (m) |
| 2023-03-31 | (m) | $191.70M | $1.21B | (m) | $83.26M | $2.51M | (m) |
| 2022-12-31 | (m) | $172.96M | $1.32B | (m) | $80.91M | $4.36M | (m) |
| 2022-09-30 | (m) | $124.82M | $1.30B | (m) | $113.66M | $5.86M | (m) |
| 2022-06-30 | (m) | $135.02M | $1.38B | (m) | $171.62M | $8.10M | (m) |
| 2022-03-31 | (m) | $159.25M | $1.49B | (m) | $167.26M | $8.70M | (m) |
| 2021-12-31 | (m) | $134.76M | $1.55B | (m) | $131.54M | $3.36M | (m) |
| 2021-09-30 | (m) | $90.31M | $1.74B | (m) | $44.67M | $3.47M | (m) |
| 2021-06-30 | (m) | $4.69M | $37.63K | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $1.42M | $1.92M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.23M | $0.00 | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $471.06M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $40.07M | $495.29M | (m) | $3.46M | $0.00 | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.